F5 and deep vein thrombosis: In this study we reported one patient with heterozygous Factor V Leiden mutation who had experienced cerebral venous thrombosis during eltrombopag treatment and, after a temporary interruption of drug, he resumed treatment and developed deep vein thrombosis of the lower limbs.